title: Initation of highly active antiretroviral therapy leads to an HIV-specific immune response in a seronegative infant.
authors.forename: Pieter L
authors.initials: PL
authors.lastname: Fraaij
authors.forename: Annemarie M
authors.initials: AM
authors.lastname: Van Rossum
authors.forename: Katja C
authors.initials: KC
authors.lastname: Wolthers
authors.forename: Ann C
authors.initials: AC
authors.lastname: Vossen
authors.forename: Yvonne M
authors.initials: YM
authors.lastname: Jeucken
authors.forename: Jac H
authors.initials: JH
authors.lastname: Kuijpers
authors.forename: Ellen G
authors.initials: EG
authors.lastname: Van Lochem
authors.forename: Marijke T
authors.initials: MT
authors.lastname: Roos
authors.forename: Ronald
authors.initials: R
authors.lastname: De Groot
authors.forename: Nico G
authors.initials: NG
authors.lastname: Hartwig
mesh_terms: D000914:Antibodies, Viral / Q000096:biosynthesis*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007223:Infant
chemical_list: D000914:Antibodies, Viral